我如何治疗高风险的MDS.
1Myeloid Malignancies Program, Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Blood
|January 14, 2025
概括
本综述讨论了更高风险的骨髓质疏松症候群 (MDS),重点关注更新的分类和预后工具. 它强调了将基因突变与传统评分系统相结合的重要性,以改善患者管理.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 骨髓质综合征 (MDS) 是一种具有缺陷血液形成的异质骨髓性恶性瘤.
- 目前的国际预后评分系统 (IPSS) 依赖于临床,形态和细胞遗传数据.
- 较高风险的MDS管理旨在延迟白血病转变并延长存活时间,使用低甲基化剂和干细胞移植作为护理标准.
研究的目的:
- 审查对高风险骨髓质疏松综合征 (MDS) 的方法.
- 纳入更新的分类和新的预后工具,包括基因组特征.
- 为了说明临床案例示例,并分享最近临床试验的见解.
主要方法:
- 审查当前的文献和临床试验数据.
- 对更新的MDS分类系统进行分析.
- 将遗传突变数据整合到预后中.
主要成果:
- 传统的IPSS缺乏全面的预后价值,因为>80%的MDS病例具有体质突变.
- 基因组特征对于预后至关重要,导致分子IPSS的发展.
- 更新的分类和分子数据增强了高风险MDS的风险分层.
结论:
- 需要对高风险的MDS进行修订方法,将分子数据与临床和细胞遗传特征整合起来.
- 新的预后工具和分类改善了患有骨髓质疏松综合征的患者的管理.
- 从临床试验中吸取的经验教训为MDS的未来治疗策略提供了信息.
相关概念视频
Bone Marrow Sampling and Transplants
277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


